CHI's Formulation Strategies for Improved Delivery of Biologics Conference, May 5-6, 2014, Boston

Overcoming Challenges in Injectable Drug Delivery via Breakthrough Delivery and Device Strategies
 
 
Spread the Word
Listed Under

Tags:
* Formulation
* Drug Delivery
* Biologics
* Biologics Delivery
* Drug Device

Industrys:
* Biotech
* Science

Location:
* Needham - Massachusetts - US

Subject:
* Events

NEEDHAM, Mass. - Feb. 19, 2014 - PRLog -- Cambridge Healthtech Institute (CHI) released today the complete program for the Formulation Strategies for Improved Delivery of Biologics conference to be held on May 5-6, 2014 at the Seaport World Trade Center in Boston, MA.

The conference will discuss new formulation approaches designed to overcome biologics delivery issues through as chemical modifications, new formulations and delivery technologies and advanced analytical tools to characterize protein interactions with excipients. These strategies have the potential to facilitate the development of next generation peptide and protein therapeutics which are safe, efficacious and promote patient compliance.

The keynote speaker will be Julia Rashba-Step, Ph.D., Senior Director, Novel Delivery Technologies, Pfizer, Inc., who will discuss the future trends on biotherapeutics and importance of drug delivery in commercial, clinical differentiation and also the need for enabling technologies. Also it will also cover strategic plans for current and future delivery reflective of needs of Pfizer’s BioTherapeutics portfolio.

Additional speakers include:
- Ajay K. Banga, Ph.D., Mercer University
- Sujit K. Basu, Ph.D., Shire
- Russell G. Burge, Ph.D., Freeslate, Inc.
- Kevin Constable, Terumo Medical Corporation
- Weiguo Dai, Ph.D., Johnson & Johnson
- Ian W. Hunter, Ph.D., MIT
- Robert Kelley, Ph.D., Genentech, Inc.
- William J. Lambert, Ph.D., MedImmune, Inc.
- Tarun Mandal, Ph.D., Xavier University of Louisiana
- Ashim K. Mitra, Ph.D., University of Missouri-Kansas City
- Carsten Olbrich, Ph.D., Bayer Pharma AG
- Robert K. Prud’homme, Ph.D., Princeton University
- Sarangapani Prasad, Ph.D., MedImmune, Inc.
- Christopher A. Rhodes, Ph.D., Christopher A. Rhodes & Associates LLC
- Amar Sawhney, Ph.D., Ocular Therapeutix, Inc
- Cindy Wu, Ph.D., Allergan, Inc.

This conference is Part 1 at CHI’s Inaugural Biologics Formulation & Delivery Summit (May 5-7).

Writers and editors are invited to attend. To request a press pass or arrange an interview with a speaker, email Lisa Scimemi: lscimemi@healthtech.com

For additional information and to register, visit www.healthtech.com/formulation-improved-biologics. Advance registration discounts and student fellowships will be offered until March 14, 2014.

About Cambridge Healthtech Institute (CHI)
Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, and The Knowledge Foundation. www.chicorporate.com

Contact
James Prudhomme
781-972-5400
***@healthtech.com
End
Source:
Email:***@healthtech.com Email Verified
Tags:Formulation, Drug Delivery, Biologics, Biologics Delivery, Drug Device
Industry:Biotech, Science
Location:Needham - Massachusetts - United States
Subject:Events
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cambridge Healthtech Institute News
Trending
Daily News
Weekly News



Like PRLog?
9K2K1K
Click to Share